7234-25-5

Basic information

• Product Name: 4-METHYL-2-METHYLSULFANYL-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: ethyl-2-methylthio-4-methyl-5-pyrimidine carboxylate;4-Methyl-2-methylsulfanyl-pyrimidine-5-carboxylic acid ethyl ester ,97%;Ethyl 4-Methyl-2-(Methylthio)-5-pyriMidinecarboxylate
• CAS NO: 7234-25-5
• Molecular Formula: C9H12N2O2S
• Molecular Weight: 212.27
• Mol File: 7234-25-5.mol
• Article Data: 9

Chemical Properties

• Melting Point: 59-60 °C
• Boiling Point: 445.6 °C at 760 mmHg
• Flash Point: 223.3 °C
• Appearance: /
• Density: 1.13 g/cm³
• Vapor Pressure: 3.89E-08mmHg at 25°C
• Refractive Index: 1.574
• Storage Temp.: 2-8°C
• PKA: -0.28±0.29(Predicted)
• CAS DataBase Reference: 4-METHYL-2-METHYLSULFANYL-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHYL-2-METHYLSULFANYL-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER(7234-25-5)
• EPA Substance Registry System: 4-METHYL-2-METHYLSULFANYL-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER(7234-25-5)

Safety Data

• Statements: 20/22
• Safety Statements: 36/37
• Hazardous Substances Data: 7234-25-5(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C18H22N2O/c1-13-16(11-19)18(14(2)17(13)21)9-6-10-20(18)12-15-7-4-3-5-8-15/h3-5,7-8,13-14,16H,6,9-10,12H2,1-2H3

Upstream product

• 14527-26-5 2-methylisothiourea sulphate 
• 141-97-9 ethyl acetoacetate 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 49836-24-0 (E)-2-(ethoxymethylene)-3-oxobutanoic acid ethyl ester 
• 66975-53-9 2-1-ethoxy-meth-(Z)-ylidene-3-oxo-butyric acid ethyl ester 
• 78-84-2 isobutyraldehyde 
• 630-19-3 pivalaldehyde 
• 147895-43-0 S-methylisothiourea hemisulphate 
• 3788-94-1 2-ethoxymethylene-3-oxobutanoic acid ethyl ester 
• 1236204-41-3 ethyl 1,4-dihydro-4-isopropyl-6-methyl-2-(methylthio)pyrimidine-5-carboxylate 
• 2986-19-8 carbamimidothioic acid methyl ester 
• 134653-70-6 α-acetyl-α-(dimethylaminomethylene)acetic acid,ethyl ester 

Downstream Products

• 74840-45-2 ethyl 6-methyl-2-methylthio-4-phenyl-3,4,5,6-tetrahydropyrimidine-5-carboxylate 
• 1554485-62-9 2-methylsulfanyl-pyrido[4.3-d]-pyrimidine 
• 1452229-91-2 6-benzyl-8-bromo-2-(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one 
• 901865-07-4 6-benzyl-2-(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452232-82-4 6-(2,6-dichlorophenyl)-8-(1-hydroxyethyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452231-63-8 tert-butyl 6-(6-(2,6-dichlorophenyl)-8-formyl-5-oxo-5,6-dihydropyrido[4,3-d]pyrimidin-2-ylamino)-3,4-dihydroisoquinoline-2(1H)-carboxylate 
• 1452231-33-2 6-(2-chloro-6-fluorophenyl)-2-(methylthio)-5-oxo-5,6-dihydropyrido[4,3-d]pyrimidine-8-carbaldehyde 
• 1452231-20-7 6-(2,6-dichlorophenyl)-8-(hydroxymethyl)-2-[(2'-methyl-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-isoquinolin]-7'-yl)amino]pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452231-11-6 2-amino-6-(2,6-dichlorophenyl)-8-(1H-imidazol-2-yl)pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452230-93-1 8-(cyclohex-1-en-1-yl)-6-ethyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452230-90-8 8-bromo-6-ethyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452230-85-1 8-bromo-6-(cyclopropylmethyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452230-84-0 6-(2,6-dichlorophenyl)-8-(hydroxymethyl)-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrido[4,3-d]pyrimidin-5(6H)-one 
• 1452230-83-9 6-(2,6-dichlorophenyl)-8-(fluoromethyl)-2-(methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one 

Relevant articles and documents

Investigation of biaryl heterocycles as inhibitors of Wee1 kinase

In continuation of our previous research towards the discovery of potent, selective and drug-like Wee1 inhibitors, 2 novel series of biaryl heterocycles were designed, synthesized and evaluated. The new biaryl cores were designed to enable structure?activ

PYRIDOPYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS

Compounds of the formula (I) in which R, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of cancer, rheumatoid arthritis and / or systemic lupus

BENZAZEPINE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

A compound having the formula (1) wherein: Ra represents C1-6 alkyl, cyclobutyl or cyclopentyl; R1 represents H or C1-6 alkyl; R2 represents H or R1 and R2 together represent =0; X1 represents CR3 or N; X2 represents CR4 or N; X3 represents CR5 or N; X4 represents CR6 or N; wherein one or two of X1, X2, X3 and X4 represents N; R3, R4, R5 and R6 each independently represent H, C1-6 alkoxy or -NR7R8; R7 and R8 independently represent H or C1-6 alkyl; or R7 and R8 and the N atom to which they are attached are joined to form a N-containing heterocyclyl ring optionally substituted with one or more substituents independently selected from halogen, C1-6 alkyl and C1-6 alkoxy; or a pharmaceutically acceptable salt thereof, is provided. Compounds of the invention have been found to modulate the histamine H3 receptor.